Purchases and Sales Made in Q2 2023 in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during Q2 2023. The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-90.9K- 47.0% |
$46.4K - $130K
|
103K
$378K
|
|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-98.1K- 36.97% |
$50K - $140K
|
167K
$617K
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-113K- 81.68% |
$57.5K - $161K
|
25.3K
$93.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-269K- 41.84% |
$137K - $385K
|
375K
$1.38M
|
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-4.7M- 37.57% |
$2.4M - $6.72M
|
7.81M
$28.8M
|